Question 1

Am I eligible for the intravenous Tamiflu treatment based on my kidney function?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza clinical trial (NCT01050257). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the intravenous form compare to the oral version in terms of effectiveness?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza clinical trial (NCT01050257). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza clinical trial (NCT01050257). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my kidney function affect the dosing of the medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza clinical trial (NCT01050257). Contact the study team or your healthcare provider for specific answers.

Question 5

What will the treatment schedule look like for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza clinical trial (NCT01050257). Contact the study team or your healthcare provider for specific answers.

What this study is about